CeQur

CeQur is a private, commercial-stage medical device company developing wearable insulin delivery solutions. Its lead product, CeQur Simplicity, is a 4-day wearable patch that delivers rapid-acting insulin on-demand via a simple button click, eliminating the need for traditional mealtime injections. The device is backed by clinical data showing improved glycemic control and adherence in people with type 1 and type 2 diabetes. The company operates from Switzerland with US operational headquarters, targeting the large and growing global diabetes management market.

Wearable, mechanical insulin delivery patch for on-demand, injection-free bolus insulin dosing via a soft cannula.

Competes directly with traditional insulin pens and syringes (Novo Nordisk, Sanofi, Eli Lilly) and with tubeless insulin pumps (Insulet Omnipod). It occupies a niche between these categories by offering multi-day wear with simple, mechanical on-demand dosing, unlike electronic pumps.